Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-20

Clinical Trial Update: Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluating omeprazole for idiopathic pulmonary fibrosis has completed. The study was sponsored by Newcastle-upon-Tyne Hospitals NHS Trust.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole (Omeprazole)

Snippet

Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED